摘要
目的 探讨中成药联合盐酸坦索罗辛缓释胶囊治疗Ⅲ型前列腺炎的临床效果,以期提高临床治疗水平.方法 随机选取2010年1月～2013年2月收治的90例Ⅲ型前列腺炎患者为研究对象,分成两组,对照组45例,采用盐酸坦索罗辛缓释胶囊治疗,观察组加用中成药制剂,比较两组治疗后的效果.结果 对照组治愈率为20.00％,显效率为26.67％,总有效率为75.56％;观察组治愈率为35.55％,显效率为46.67％,总有效率为91.11％.两组比较有显著性差异（P＜0.05）.在疼痛不适、排尿症状、NIH-CPSI评分、生活质量、MFR、AFR等指标两组治疗前比较无显著差异（P＞0.05）,而治疗后两组比较有显著性差异（P＜0.05）.结论 中成药联合盐酸坦索罗辛缓释胶囊治疗Ⅲ型前列腺炎临床效果满意,安全性高.
Objective To investigate medicine tamsulosin hydroehloride sustained-release capsules combined treatment of type III prostatitis clinical resuhs＇ in order to improve the level of clinical treatment. Methods Randomly selected in January 2010 to February 2013 90 eases of type III prostatitis patients for the study, divided into two groups, the control group of 45 patients, used tamsulosin hydroehlofide sustained-release capsules treatment, observation group were treated with Chinese patent medicine formulations were compared after treatment the effect of the difference. Results The cure rate of the control group was 20.00%, effective rate was 26.67%, total effective rate was 75.56%; observation group cure rate was 35.55%, effective rate was 46.67%, total effective rate was 91.11%. Two groups had significant difference （P 〈0.05）. In pain and discomfort, urinary symptoms, NIH-CPSI score, quality of life, MFR, AFR of the two groups before treatment showed no difference （P 〉0.05）, while the two groups after treatment there was significant dif- ference （P 〈0.05）, there statistically significant. Conclusion Tamsulosin sustained-release capsules medicine combined treatment of type III prostatitis clinical results are satisfactory and safe.
出处
《中国现代医生》
2014年第22期99-101,共3页
China Modern Doctor
基金
浙江省医学会医学发展计划资助项目(2010-ZW046)
关键词
中成药
盐酸坦索罗辛缓释胶囊
Ⅲ型前列腺炎
临床效果
Chinese patent medicine
Tamsulosin hydreehloride release capsules
Type Ill prostatitis
Clinical effects
